Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Expression analysis of genes involved in fat assimilation in human monocytes.

Klapper M, Döpner M, Vock C, Nitz I, Helwig U, Schrezenmeir J, Döring F.

IUBMB Life. 2006 Jul;58(7):435-40.

2.

Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.

Westerbacka J, Kolak M, Kiviluoto T, Arkkila P, Sirén J, Hamsten A, Fisher RM, Yki-Järvinen H.

Diabetes. 2007 Nov;56(11):2759-65. Epub 2007 Aug 17.

3.

Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.

Oikari S, Ahtialansaari T, Huotari A, Kiehne K, Fölsch UR, Wolffram S, Jänne J, Alhonen L, Herzig KH.

Acta Physiol (Oxf). 2008 Sep;194(1):57-65. doi: 10.1111/j.1748-1716.2008.01860.x. Epub 2008 Apr 3.

PMID:
18394026
4.

Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.

Kohjima M, Enjoji M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, Yada M, Yada R, Harada N, Takayanagi R, Nakamuta M.

Int J Mol Med. 2007 Sep;20(3):351-8.

PMID:
17671740
5.

Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes.

De Gottardi A, Vinciguerra M, Sgroi A, Moukil M, Ravier-Dall'Antonia F, Pazienza V, Pugnale P, Foti M, Hadengue A.

Lab Invest. 2007 Aug;87(8):792-806. Epub 2007 Jun 11.

7.

PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.

Seo YS, Kim JH, Jo NY, Choi KM, Baik SH, Park JJ, Kim JS, Byun KS, Bak YT, Lee CH, Kim A, Yeon JE.

J Gastroenterol Hepatol. 2008 Jan;23(1):102-9. doi: 10.1111/j.1440-1746.2006.04819.x. Erratum in: J Gastroenterol Hepatol. 2009 May;24(5):932. J Gastroenterol Hepatol. 2009 Jul;24(7):1310.

PMID:
18171348
8.
9.

18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.

Anandharajan R, Sayyed SG, Doshi LS, Dixit P, Chandak PG, Dixit AV, Brahma MK, Deshmukh NJ, Gupte R, Damre A, Suthar J, Padigaru M, Sharma SD, Nemmani KV.

Metabolism. 2009 Oct;58(10):1503-16. doi: 10.1016/j.metabol.2009.04.036. Epub 2009 Jul 15.

10.

Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease.

Holvoet P.

Verh K Acad Geneeskd Belg. 2008;70(3):193-219. Review.

PMID:
18669160
11.

The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.

Nakamuta M, Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Yada M, Yada R, Takemoto R, Fukuizumi K, Harada N, Taketomi A, Maehara Y, Nakashima M, Enjoji M.

Int J Mol Med. 2008 Nov;22(5):663-7.

PMID:
18949388
12.

Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.

Berthiaume M, Laplante M, Tchernof A, Deshaies Y.

Int J Obes (Lond). 2007 Nov;31(11):1660-70. Epub 2007 Jun 19.

PMID:
17579631
13.

PPARgamma regulates the function of human dendritic cells primarily by altering lipid metabolism.

Szatmari I, Töröcsik D, Agostini M, Nagy T, Gurnell M, Barta E, Chatterjee K, Nagy L.

Blood. 2007 Nov 1;110(9):3271-80. Epub 2007 Jul 30.

14.

Calcium/calmodulin-dependent protein kinase II in human articular chondrocytes.

Shimazaki A, Wright MO, Elliot K, Salter DM, Millward-Sadler SJ.

Biorheology. 2006;43(3-4):223-33.

PMID:
16912396
15.

Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.

Minoura H, Takeshita S, Kimura C, Hirosumi J, Takakura S, Kawamura I, Seki J, Manda T, Mutoh S.

Diabetes Obes Metab. 2007 May;9(3):369-78.

PMID:
17391165
16.

Amyloid precursor protein expression is upregulated in adipocytes in obesity.

Lee YH, Tharp WG, Maple RL, Nair S, Permana PA, Pratley RE.

Obesity (Silver Spring). 2008 Jul;16(7):1493-500. doi: 10.1038/oby.2008.267. Epub 2008 May 15.

17.

Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.

Hu WL, Qiao SB, Li JJ.

Cytokine. 2007 Dec;40(3):201-6. Epub 2007 Nov 19. Erratum in: Cytokine. 2009 Jun;46(3):392. Qian, Shu-Bing [corrected to Qiao, Shu-Bin].

PMID:
18023360
18.

Glycerol kinase deficiency alters expression of genes involved in lipid metabolism, carbohydrate metabolism, and insulin signaling.

Rahib L, MacLennan NK, Horvath S, Liao JC, Dipple KM.

Eur J Hum Genet. 2007 Jun;15(6):646-57. Epub 2007 Apr 4.

19.

Fatty acid transport protein 4 is the principal very long chain fatty acyl-CoA synthetase in skin fibroblasts.

Jia Z, Moulson CL, Pei Z, Miner JH, Watkins PA.

J Biol Chem. 2007 Jul 13;282(28):20573-83. Epub 2007 May 23.

20.

The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-gamma target genes, in dogs.

Gayet C, Leray V, Saito M, Siliart B, Nguyen P.

Br J Nutr. 2007 Sep;98(3):497-503. Epub 2007 May 3.

PMID:
17475082

Supplemental Content

Support Center